Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
{ "CareMeds Intervention for Pediatric Acute Lymphoblastic Leukemia", "This study is testing a program called CareMeds, which involves three parenting sessions, to see if it can help parents of children with acute lymphoblastic leukemia (ALL) better manage their child's medication. The study aims to find out if the CareMeds intervention is practical and acceptable for families. You might be able to join if you are a parent of a child aged 3 to 9 years old with ALL who takes home-based oral anti-cancer medication like 6-MP, and you are fluent in English or Spanish. The study is looking to enroll 100 families across sites in Buffalo, NY, and Atlanta, GA. The main goal is to see if the CareMeds sessions are feasible to deliver.", "design": "This is a pilot randomized controlled trial with 100 participants. Some families will receive the CareMeds intervention early, while others will receive usual care first.", "commitments": "Participants will attend three parenting sessions. These sessions will occur during weeks 2-4 for the CareMeds group or weeks 13-15 for the usual care group.", "compensation": "Not stated in the trial record.", "follow_up": "The feasibility of the CareMeds sessions will be measured for up to 3 years.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
At a glance
Conditions
NCT06074666
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Roswell Park Comprehensive Cancer Center
Buffalo, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Elizabeth Bouchard, PhD · PRINCIPAL_INVESTIGATOR · Roswell Park Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility of the CareMeds 3 sessionsup to 3 years
enrollment rates will be measured by number of consents . Reasons for refusal will also be captured